IP Library › Granted Patent US 10,442,826
Granted Patent B2
US 10,442,826 · App. 15/962,934 · Granted Oct 15, 2019

Water-soluble acetaminophen analogs

Inventors: Naweed Muhammad (Fremont, CA); Keith R. Bley (Menlo Park, CA)
Assignee: Acorda Therapeutics, Inc.
C07F9/094A61K9/0019A61K31/661A61K45/06C07F9/091
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,442,826
App. No.
15/962,934
Granted
Oct 15, 2019
Kind
B2
Abstract

The present invention provides water-soluble acetaminophen prodrugs and formulations which may be suitable for parenteral administration. Methods of treating a disease or condition responsive to acetaminophen (such as fever and/or pain) using the acetaminophen prodrugs, as well as kits, unit dosages, and combinations with additional pharmaceutical agent(s) are also provided.

Claims (22)

1. A process for preparing a compound of formula (I)

or a pharmaceutically acceptable salt thereof,

comprising the steps of:

(a) reacting a compound of formula SI-A:

with a halomethyl sulfide to provide a compound of the formula

(b) reacting the compound of the formula

with dibenzylphosphate to provide a compound of the formula

wherein Bn is benzyl;

(c) deprotecting the compound of the formula

to provide the compound of formula (I); and

(d) optionally converting the compound of formula (I) into a pharmaceutically acceptable salt thereof.

2. The process of claim 1 , wherein the halomethyl sulfide of step (a) is chloromethyl methyl sulfide.

3. The process of claim 1 , wherein step (a) is performed using HMPA as a solvent.

4. The process of claim 1 , wherein step (a) further comprises NaH.

5. The process of claim 1 , wherein step (b) is performed using THF as a solvent.

6. The process of claim 1 , wherein step (b) further comprises NIS or NBS.

7. The process of claim 1 , wherein step (c) is performed under reducing conditions.

8. The process of claim 1 , wherein step (c) is performed using Pd(OH) 2 /H 2 .

9. The process of claim 1 , wherein step (c) is performed using acidic conditions.

10. The process of claim 9 , wherein step (c) comprises treatment with acetic acid.

11. The process of claim 1 , wherein step (c) is performed using a protic solvent.

12. The process of claim 11 , wherein the protic solvent is methanol.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2018
From: MUHAMMAD, NAWEED; BLEY, KEITH R.
To: NEUROGESX, INC.
Reel/Frame 045681/0502 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2018
From: NEUROGESX, INC.
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 046050/0853 →
Continuity (4)
Continuation 15077802 · Mar 22, 2016
Continuation 12993088
Provisional Application 61054774 · May 20, 2008
Related Publication 20190092795A1 · Mar 28, 2019